New hope for Tough-to-Treat cancer: experimental drug enters human trials
NCT ID NCT06132113
Summary
This early-stage study is testing a new drug called BI 764532, given by IV along with standard chemotherapy, for adults with an aggressive type of neuroendocrine cancer. The main goal is to find the safest and most tolerable dose of the new combination. Researchers will also check if the treatment helps shrink tumors in patients whose cancer has a specific marker called DLL3.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aichi Cancer Center Hospital
RECRUITINGAichi, Nagoya, 464-8681, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Akademiska hospital
NOT_YET_RECRUITINGUppsala, 751 85, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cliniques Universitaires Saint-Luc
RECRUITINGBrussels, 1200, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOP Louis Pradel
NOT_YET_RECRUITINGBron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitari Vall D Hebron
RECRUITINGBarcelona, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario La Paz
RECRUITINGMadrid, 28046, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
INS Paoli-Calmettes
RECRUITINGMarseille, 13009, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
John Theurer Cancer Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Klinikum der Universität München AÖR
NOT_YET_RECRUITINGMünchen, 81377, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Cancer Center Hospital
RECRUITINGTokyo, Chuo-ku, 104-0045, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Cancer Center Hospital East
RECRUITINGChiba, Kashiwa, 277-8577, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Northwestern University
NOT_YET_RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Osaka International Cancer Institute
RECRUITINGOsaka, Osaka, 541-8567, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sahlgrenska Universitetsjukhuset
RECRUITINGGothenburg, 413 46, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitair Medisch Centrum Groningen
RECRUITINGGroningen, 9713 GZ, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Tübingen
RECRUITINGTübingen, 72076, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.